GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Polyplex Corporation Ltd

Polyplex Q2 FY27 Consolidated Results: Revenue Rs. 2,320 Cr, Normalized EBITDA Rs. 327 Cr

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 16 Nov 2026, 05:24 PM IST  ·  BSE ID: b8b7c359-79fb-405b-a3a7-838f6bdeda79
View Original BSE Filing (PDF)
💡
In Simple Terms
Polyplex Corporation reported higher sales and profits in its latest quarterly results compared to the same period last year.
🤖 AI Summary
  • Polyplex Corporation presented consolidated financial results for Q2 FY27 and H1 FY27, ended September 30, 2026.
  • Q2 FY27 sales revenue reached INR 2,320 Crores, a 29% YoY increase from Q2 FY26-27.
  • Normalized EBITDA for Q2 FY27 stood at INR 327 Crores, growing 137% compared to Q2 FY25-26.
  • PAT (Before Minority) for Q2 FY27 was INR 180 Crores, with EPS of INR 31.93/Share.
  • H1 FY27 sales revenue was INR 4,569 Crores, an increase of 30% YoY from H1 FY25-26.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Q2 FY27 Sales Volume (All Films)
88.5 KMT
6%
Q2 FY27 Sales Revenue
2,320 INR Crores
29%
Q2 FY27 Normalized EBITDA
327 INR Crores
137%
Q2 FY27 PAT (Before Minority)
180 INR Crores
Not comparable — limited prior period data.
Q2 FY27 EPS
31.93 INR/Share
Not comparable — limited prior period data.
H1 FY27 Sales Volume (All Films)
180 KMT
3%
H1 FY27 Sales Revenue
4,569 INR Crores
30%
H1 FY27 Normalized EBITDA
689 INR Crores
113%
H1 FY27 PAT (Before Minority)
351 INR Crores
Not comparable — limited prior period data.
H1 FY27 EPS
60.93 INR/Share
Not comparable — limited prior period data.
🏢 How This Affects the Company
📈
Business Impact
The company reported higher sales volumes and revenues, reflecting improved realizations and strategic focus on Differentiated Products & Coating (DPAC) and Specialty Films. This suggests a strengthening market position in specialty film segments.
💰
Financial Impact
Normalized EBITDA and PAT (Before Minority) show significant year-over-year increases, indicating improved profitability and operational efficiency. The unrealized FX gain in Q2 FY27 also positively impacted financial results compared to prior periods.
⚙️
Operational Impact
Sales volume increased 3% QoQ and 6% YoY for Q2 FY27, with total base films capacity at 504k MTPA. This indicates stable manufacturing operations despite a planned shutdown at the Indonesia plant during the quarter.
⚠️
Risk Impact
The company notes improved realizations due to pass-through of higher raw material costs amid geopolitical uncertainties, indicating a managed exposure to commodity price volatility. Withdrawal of reciprocal tariffs partially offset by Section 301 tariffs also had an overall positive impact on US Distribution business margins.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from shareholders based on this results presentation.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, with Q2 FY27 EPS reported at INR 31.93/Share and H1 FY27 EPS at INR 60.93/Share.
🔍
Management Signal
The presentation highlights management's focus on operational efficiencies, cost optimization, and strategic growth through Differentiated Products & Coating (DPAC) and Specialty Films.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results for continued performance trends.
Updates on new PET film line in India, planned for 2027.
Progress on specialty BOPP film line in Thailand, planned for 2028.
MEDIUM RISK Exposure to geopolitical uncertainties and raw material cost fluctuations remains, despite passing on costs.
💡 Investor Takeaway
Polyplex Corporation reported strong Q2 FY27 consolidated financial results, with Sales Revenue at INR 2,320 Crores (up 29% YoY) and Normalized EBITDA at INR 327 Crores (up 137% YoY). PAT (Before Minority) was INR 180 Crores. H1 FY27 Sales Revenue grew 30% YoY to INR 4,569 Crores.
⚖️ Strengths & Concerns

✅ Positives

  • Q2 FY27 Sales Revenue of INR 2,320 Crores grew 29% YoY, driven by improved sales realizations.
  • Normalized EBITDA for Q2 FY27 increased 137% YoY to INR 327 Crores, demonstrating significant profitability growth.

⚠️ Concerns

  • Shareholders' Total Returns (CAGR) for Polyplex declined -10% over the last 5 years, underperforming Nifty 500-TRI and BSE Small Cap-TRI.
  • Sales Volume (All Films) for H1 FY27 grew only 3% YoY to 180 KMT, indicating modest volume expansion.
📅 Company Track Record
Polyplex Corporation's Q2 FY27 standalone net profit surged 152.72% to Rs. 3,154 Lakh, according to the financial results filed on November 13, 2026. This indicates a strong performance trend in the recent quarter.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Polyplex Corporation's consolidated sales revenue in Q2 FY27?
Polyplex Corporation reported a consolidated sales revenue of INR 2,320 Crores for Q2 FY27, representing a 29% YoY growth.
What was Polyplex Corporation's Normalized EBITDA for Q2 FY27?
The Normalized EBITDA for Polyplex Corporation in Q2 FY27 was INR 327 Crores, which is a 137% increase compared to Q2 FY25-26.
What was Polyplex Corporation's PAT (Before Minority) in Q2 FY27?
Polyplex Corporation's PAT (Before Minority) for Q2 FY27 stood at INR 180 Crores, with an EPS of INR 31.93/Share.
How did Polyplex Corporation's Sales Volume perform in H1 FY27?
Polyplex Corporation's Sales Volume (All Films) for H1 FY27 reached 180 KMT, indicating a 3% YoY growth.
What is Polyplex Corporation's total base films capacity?
Polyplex Corporation has a total base films capacity of 504k MTPA, with BOPET Films accounting for 365k MTPA.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel